Indications - Empagliflozin & Linagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.

Dosage & Administration - The recommended dose is Empagliflozin & Linagliptin 10/ 5 once daily, taken in the morning, with or without food. Dose may be increased to Empagliflozin & Linagliptin 25/5 once daily.

Side Effects - Data note update

Contraindications - Data note update

Others - Data note update